補助人工心臓（VAD）の世界市場レポート 2024

補助人工心臓（VAD）の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には12.6%の年間複合成長率（CAGR）で35億米ドルに成長すると予想されます。予測される成長は、目的の治療に対する需要の増加、人口の高齢化、医療支出の増加、心不全治療に対する意識の高まりによるものです。主な動向には、VADの寿命延長、デバイスの小型化、高度なポンプ技術、安全性/有効性の向上、副作用の軽減、経皮的VADが含まれます。

心血管疾患の世界の急増は、補助人工心臓（VAD）市場の拡大の原動力となっています。高血圧、喫煙、高コレステロール、運動不足などの要因に起因する心血管障害が増加しています。糖尿病、慢性呼吸器疾患、高血圧に関連する心臓発作などの非伝染性疾患は、心血管障害の有病率の増加に寄与しています。この傾向は、重症の心臓病患者にとって重要なサポートシステムとして機能する補助人工心臓（VAD）に対する需要の高まりを浮き彫りにしています。例えば、2021年に世界保健機関は、脳卒中と虚血性心疾患による世界の死亡者数の5分の1をインドが占めると予想され、特に若年層が罹患すると報告しました。さらに、予測によれば、米国では2030年までに約1,210万人が心房細動（A-Fib）を経験すると予想されています。心血管障害の有病率の増加により、予測期間中に補助人工心臓（VAD）の需要が大幅に高まると見込まれています。

心不全治療に対する意識の高まりは、補助人工心臓（VAD）市場の成長を促進すると予想される極めて重要な要素です。心不全は、心臓が効果的に血液を送り出す能力の低下を特徴としており、冠状動脈疾患、心臓発作、高血圧、心筋損傷などの症状が原因で発生することがあります。心不全治療に対する意識の高まりにより、心不全に対処する手段として補助人工心臓（VAD）の採用が促進されることが予想されます。特に、米国心臓協会は、2030年までに心不全の診断が46%増加し、心不全患者が800万人を超えると予測しています。心不全と診断される人の数が増加し続ける中、利用可能な治療選択肢に対する意識の高まりが、補助人工心臓（VAD）市場の主要な原動力となる見込みです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の補助人工心臓（VAD）市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 左心補助人工心臓（LVAD）
• 右心補助人工心臓（RVAD）
• 両心補助人工心臓（BiVAD）
• 世界の補助人工心臓（VAD）市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 脈動流
• 連続流
• 世界の補助人工心臓（VAD）市場、設計別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経皮的補助人工心臓（VAD）
• 植込み型補助人工心臓（VAD）
• 世界の補助人工心臓（VAD）市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• BTT療法
• DT
• BTR療法
• BTC療法
• 世界の補助人工心臓（VAD）市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 外来手術センター
• 心臓病センター

第7章 地域および国の分析

• 世界の補助人工心臓（VAD）市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の補助人工心臓（VAD）市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 補助人工心臓（VAD）市場の競合情勢
• 補助人工心臓（VAD）市場の企業プロファイル
  • Abiomed Inc
  • Abbott Laboratories
  • Medtronic
  • LivaNova PLC
  • Terumo Corporation

第31章 その他の大手および革新的な企業

• Berlin Heart GmbH
• Cirtec
• Jarvik Heart Inc.
• SynCardia Systems LLC.
• Calon Cardio-Technology Ltd
• Huadong Medicine Co. Ltd
• Shenzhen Hexin Zondan Medical Equipment Co. Ltd
• Sun Medical Technology Research Corp.
• Boston Scientific Corporation
• CorWave SA
• CH Biomedical（USA）Inc
• Evaheart Inc
• BiVACOR Inc
• ReliantHeart Inc
• Cardiac Assist Inc

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

A ventricular assist device (VAD) is an implantable mechanical circulatory device used to treat heart failure by aiding blood circulation throughout the body, supporting vital organ function. The US FDA has approved a diverse range of VADs, offering long-term or permanent assistance for patients with end-stage heart failure.

The primary types of VADs include left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). LVADs, battery-operated mechanical pumps, help propel blood from the left ventricle to vital organs. They vary in design as transcutaneous or implantable devices and operate with different flow mechanisms such as pulsatile flow and continuous flow. These devices are used for various purposes including bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy. End-users of VADs include hospitals, ambulatory surgical centers, and cardiology centers.

The ventricular assist device market research report is one of a series of new reports from The Business Research Company that provides ventricular assist device market statistics, including ventricular assist device industry global market size, regional shares, competitors with a ventricular assist device market share, detailed ventricular assist device market segments, market trends and opportunities, and any further data you may need to thrive in the ventricular assist device industry. This ventricular assist device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ventricular assist device market size has grown rapidly in recent years. It will grow from $1.92 billion in 2023 to $2.18 billion in 2024 at a compound annual growth rate (CAGR) of 13.3%. Historical growth can be attributed to the increased prevalence of heart failure and a heightened demand for organ transplantation procedures.

The ventricular assist device market size is expected to see rapid growth in the next few years. It will grow to $3.5 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. Forecasted growth is due to increased demand for destination therapy, an aging population, higher healthcare spending, and greater awareness of heart failure treatments. Key trends include extending VAD lifespan, device miniaturization, advanced pump tech, improved safety/efficacy, reduced side effects, and percutaneously inserted VADs.

The surge in cardiovascular disorders globally is a driving force behind the expansion of the ventricular assist device market. Cardiovascular disorders, stemming from factors such as high blood pressure, smoking, high cholesterol, and inactivity, are on the rise. Noncontagious diseases such as diabetes, chronic respiratory illnesses, and heart attacks linked to hypertension contribute to the escalating prevalence of cardiovascular disorders. This trend underscores the heightened demand for ventricular assist devices, serving as crucial support systems for severely ill cardiac patients. For instance, in 2021, the World Health Organization reported that India was anticipated to account for one-fifth of global deaths from stroke and ischemic heart disease, particularly affecting younger adults. Moreover, projections indicate that around 12.1 million people in the U.S. are expected to experience atrial fibrillation (A-Fib) by 2030. The mounting prevalence of cardiovascular disorders is poised to drive significant demand for ventricular assist devices in the forecast period.

The increased awareness surrounding heart failure treatment is a pivotal factor expected to fuel the growth of the ventricular assist device market. Heart failure, characterized by the heart's diminished ability to effectively pump blood, can result from conditions such as coronary artery disease, heart attacks, high blood pressure, and heart muscle damage. The escalating awareness about heart failure treatments is anticipated to drive the adoption of ventricular assist devices as a means to address heart failure. Notably, the American Heart Association projects a 46% increase in heart failure diagnoses by 2030, surpassing 8 million individuals affected. As the number of people diagnosed with heart failure continues to rise, the heightened awareness of available treatment options is poised to be a key driver for the ventricular assist device market.

Technological advancements stand out as a prominent trend gaining traction in the ventricular assist device market. Companies within the ventricular assist device sector are directing their efforts toward the development of next-generation devices that enhance blood circulation. Key industry players are prioritizing the creation of ventricular assist devices with innovative technologies to gain a competitive advantage and fortify their market positions. An illustrative example is the initiative by CorWave, a France-based medical technology company, in 2021. CorWave successfully developed left ventricular assist device (LVAD) membrane pump technology. This LVAD membrane pump employs a pulse pump, utilizing electromagnetic pulses rather than a rotary pump, to facilitate blood movement, closely mimicking the natural pulsatile action of the heart.

The adoption of percutaneously inserted ventricular assist devices is gaining prominence in the market. Percutaneously inserted ventricular assist devices are non-pulsatile axial flow pumps positioned across the aortic valve, pumping blood from the left ventricle. These devices alleviate the load on the left ventricle, decrease myocardial oxygen consumption, enhance cardiac output, and reduce left ventricular end-diastolic pressure. As an example, in August 2022, Abiomed Inc., a US-based medical device company, introduced the Impella, a percutaneous VAD designed for eligible pediatric patients in the USA. The Impella device provides effective cardiac support to compensate for a failing left ventricle and can serve as an alternative to extracorporeal membrane oxygenation (ECMO) or complement other therapies to enhance hemodynamics.

In August 2022, Medtronic PLC, an Ireland-based medical device company, acquired Affera, Inc. for $925 million. This strategic acquisition broadens Medtronic's portfolio of cardiac ablation products, introducing their initial cardiac mapping and navigation platform. The platform includes radiofrequency ablation, focal pulsed field, and an integrated diagnostic solution. Affera Inc., a US-based medical technology company, specializes in cardiac mapping and navigation systems, along with catheter-based cardiac ablation technologies.

Major companies operating in the ventricular assist device market report are Abiomed Inc, Abbott Laboratories, Medtronic, LivaNova PLC, Terumo Corporation, Berlin Heart GmbH, Cirtec, Jarvik Heart Inc., SynCardia Systems LLC., Calon Cardio-Technology Ltd., Huadong Medicine Co. Ltd., Shenzhen Hexin Zondan Medical Equipment Co. Ltd., Sun Medical Technology Research Corp., Boston Scientific Corporation, CorWave SA, CH Biomedical (USA) Inc., Evaheart Inc., BiVACOR Inc., ReliantHeart Inc., Cardiac Assist Inc., Heart Ware International, Braile Biomedica Ltd

North America was the largest region in the ventricular assist device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ventricular assist device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ventricular assist device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The ventricular assist device market consists of sales of pulsatile and nonpulsatile LVADs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ventricular Assist Device Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ventricular assist device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ventricular assist device? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ventricular assist device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Left Ventricular Assist Devices (LVADs); Right Ventricular Assist Devices (RVADs); Biventricular Assist Devices (BIVADs).
• 2) By Type: Pulsatile Flow; Continuous Flow
• 3) By Design: Transcutaneous Ventricular Assist Devices; Implantable Ventricular Assist Devices
• 4) By Application: Bridge-To-Transplant (BTT) Therapy; Destination Therapy; Bridge-To-Recovery (BTR) Therapy; Bridge-To-Candidacy (BTC) Therapy
• 5) By End Users: Hospital; Ambulatory Surgical Centers; Cardiology Centers
• Companies Mentioned: Abiomed Inc; Abbott Laboratories; Medtronic; LivaNova PLC; Terumo Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ventricular Assist Device Market Characteristics

3. Ventricular Assist Device Market Trends And Strategies

4. Ventricular Assist Device Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Ventricular Assist Device Market Size and Growth

• 5.1. Global Ventricular Assist Device Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Ventricular Assist Device Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Ventricular Assist Device Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ventricular Assist Device Market Segmentation

• 6.1. Global Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Biventricular Assist Devices (BIVADs)
• 6.2. Global Ventricular Assist Device Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pulsatile Flow
• Continuous Flow
• 6.3. Global Ventricular Assist Device Market, Segmentation By Design, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Transcutaneous Ventricular Assist Devices
• Implantable Ventricular Assist Devices
• 6.4. Global Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Bridge-to-Transplant (BTT) Therapy
• Destination Therapy
• Bridge-to-Recovery (BTR) Therapy
• Bridge-to-Candidacy (BTC) Therapy
• 6.5. Global Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Cardiology Centers

7. Ventricular Assist Device Market Regional And Country Analysis

• 7.1. Global Ventricular Assist Device Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Ventricular Assist Device Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ventricular Assist Device Market

• 8.1. Asia-Pacific Ventricular Assist Device Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ventricular Assist Device Market

• 9.1. China Ventricular Assist Device Market Overview
• 9.2. China Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ventricular Assist Device Market

• 10.1. India Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ventricular Assist Device Market

• 11.1. Japan Ventricular Assist Device Market Overview
• 11.2. Japan Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ventricular Assist Device Market

• 12.1. Australia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ventricular Assist Device Market

• 13.1. Indonesia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ventricular Assist Device Market

• 14.1. South Korea Ventricular Assist Device Market Overview
• 14.2. South Korea Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ventricular Assist Device Market

• 15.1. Western Europe Ventricular Assist Device Market Overview
• 15.2. Western Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ventricular Assist Device Market

• 16.1. UK Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ventricular Assist Device Market

• 17.1. Germany Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ventricular Assist Device Market

• 18.1. France Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ventricular Assist Device Market

• 19.1. Italy Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ventricular Assist Device Market

• 20.1. Spain Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ventricular Assist Device Market

• 21.1. Eastern Europe Ventricular Assist Device Market Overview
• 21.2. Eastern Europe Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ventricular Assist Device Market

• 22.1. Russia Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ventricular Assist Device Market

• 23.1. North America Ventricular Assist Device Market Overview
• 23.2. North America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ventricular Assist Device Market

• 24.1. USA Ventricular Assist Device Market Overview
• 24.2. USA Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ventricular Assist Device Market

• 25.1. Canada Ventricular Assist Device Market Overview
• 25.2. Canada Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ventricular Assist Device Market

• 26.1. South America Ventricular Assist Device Market Overview
• 26.2. South America Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ventricular Assist Device Market

• 27.1. Brazil Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ventricular Assist Device Market

• 28.1. Middle East Ventricular Assist Device Market Overview
• 28.2. Middle East Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ventricular Assist Device Market

• 29.1. Africa Ventricular Assist Device Market Overview
• 29.2. Africa Ventricular Assist Device Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Ventricular Assist Device Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Ventricular Assist Device Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ventricular Assist Device Market Competitive Landscape And Company Profiles

• 30.1. Ventricular Assist Device Market Competitive Landscape
• 30.2. Ventricular Assist Device Market Company Profiles
  • 30.2.1. Abiomed Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott Laboratories
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medtronic
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. LivaNova PLC
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Terumo Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Ventricular Assist Device Market Other Major And Innovative Companies

• 31.1. Berlin Heart GmbH
• 31.2. Cirtec
• 31.3. Jarvik Heart Inc.
• 31.4. SynCardia Systems LLC.
• 31.5. Calon Cardio-Technology Ltd
• 31.6. Huadong Medicine Co. Ltd
• 31.7. Shenzhen Hexin Zondan Medical Equipment Co. Ltd
• 31.8. Sun Medical Technology Research Corp.
• 31.9. Boston Scientific Corporation
• 31.10. CorWave SA
• 31.11. CH Biomedical (USA) Inc
• 31.12. Evaheart Inc
• 31.13. BiVACOR Inc
• 31.14. ReliantHeart Inc
• 31.15. Cardiac Assist Inc

32. Global Ventricular Assist Device Market Competitive Benchmarking

33. Global Ventricular Assist Device Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Ventricular Assist Device Market

35. Ventricular Assist Device Market Future Outlook and Potential Analysis

• 35.1 Ventricular Assist Device Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Ventricular Assist Device Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Ventricular Assist Device Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer